The contract will apply to Highmark’s commercial insurance members in national and Pennsylvania, West Virginia and Delaware markets. Highmark said the contract marks one of the first outcomes-based agreements for a drug treating the chronic lung diseases.
Under the contract, if Highmark members who use Symbicort don’t have aligned results with clinical trials performed by AstraZeneca, the drugmaker will issue Highmark a rebate.
More articles on supply chain:
‘We can’t view ourselves as the box pushers of a hospital’: 3 experts discuss the evolving hospital supply chain
CVS Health elevates Kevin Hourican to president of CVS Pharmacy: 4 things to know
Coastal Meds recalls all drug products marketed as sterile
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
